Language:
  
[Sign in] [Register]   

EIAab logo

Index > Protein center > MYH9(Gene name) > Human
  • Add your favorite
  • MYH9 (Gene name),
  • Myosin-9 (Protein name ),  MYH9_HUMAN from NCBI database.
  • top
  • Come back to page head.
  • |
  • General Annotation
  • |
  • Antigen Annotation
  • |
  • 3D
  • |
  • Predicted Eptitope
  • |
  • Vaild Sequence
  • |
  • Related Databases
  • |
  • Feedback
  • Gene name:
    MYH9;
    Protein name:
    Myosin-9;
    Alternative:
    Myosin heavy chain 9;Cellular myosin heavy chain, type A;Non-muscle myosin heavy chain A(NMMHC-A);Myosin heavy chain, non-muscle IIa;Non-muscle myosin heavy chain IIa(NMMHC II-a;NMMHC-IIA);
    Organism:
    Human (Homo sapiens). 
    General Annotation
    Sub Unit:
    Interacts with PDLIM2 (By similarity). Interacts with SLC6A4 (By similarity). Myosin is a hexameric protein that consists of 2 heavy chain subunits (MHC), 2 alkali light chain subunits (MLC) and 2 regulatory light chain subunits (MLC-2). Interacts with SVIL.
    Function:
    Cellular myosin that appears to play a role in cytokinesis, cell shape, and specialized functions such as secretion and capping.
    Subcellular Location:
    N/A
    Protein Attributes:
    Sequence length:
    1960
    Sequence:
    50:
    MAQQAADKYL | YVDKNFINNP | LAQADWAAKK | LVWVPSDKSG | FEPASLKEEV | 
    100:
    GEEAIVELVE | NGKKVKVNKD | DIQKMNPPKF | SKVEDMAELT | CLNEASVLHN | 
    150:
    LKERYYSGLI | YTYSGLFCVV | INPYKNLPIY | SEEIVEMYKG | KKRHEMPPHI | 
    200:
    YAITDTAYRS | MMQDREDQSI | LCTGESGAGK | TENTKKVIQY | LAYVASSHKS | 
    250:
    KKDQGELERQ | LLQANPILEA | FGNAKTVKND | NSSRFGKFIR | INFDVNGYIV | 
    300:
    GANIETYLLE | KSRAIRQAKE | ERTFHIFYYL | LSGAGEHLKT | DLLLEPYNKY | 
    350:
    RFLSNGHVTI | PGQQDKDMFQ | ETMEAMRIMG | IPEEEQMGLL | RVISGVLQLG | 
    400:
    NIVFKKERNT | DQASMPDNTA | AQKVSHLLGI | NVTDFTRGIL | TPRIKVGRDY | 
    450:
    VQKAQTKEQA | DFAIEALAKA | TYERMFRWLV | LRINKALDKT | KRQGASFIGI | 
    500:
    LDIAGFEIFD | LNSFEQLCIN | YTNEKLQQLF | NHTMFILEQE | EYQREGIEWN | 
    550:
    FIDFGLDLQP | CIDLIEKPAG | PPGILALLDE | ECWFPKATDK | SFVEKVMQEQ | 
    600:
    GTHPKFQKPK | QLKDKADFCI | IHYAGKVDYK | ADEWLMKNMD | PLNDNIATLL | 
    650:
    HQSSDKFVSE | LWKDVDRIIG | LDQVAGMSET | ALPGAFKTRK | GMFRTVGQLY | 
    700:
    KEQLAKLMAT | LRNTNPNFVR | CIIPNHEKKA | GKLDPHLVLD | QLRCNGVLEG | 
    750:
    IRICRQGFPN | RVVFQEFRQR | YEILTPNSIP | KGFMDGKQAC | VLMIKALELD | 
    800:
    SNLYRIGQSK | VFFRAGVLAH | LEEERDLKIT | DVIIGFQACC | RGYLARKAFA | 
    850:
    KRQQQLTAMK | VLQRNCAAYL | KLRNWQWWRL | FTKVKPLLQV | SRQEEEMMAK | 
    900:
    EEELVKVREK | QLAAENRLTE | METLQSQLMA | EKLQLQEQLQ | AETELCAEAE | 
    950:
    ELRARLTAKK | QELEEICHDL | EARVEEEEER | CQHLQAEKKK | MQQNIQELEE | 
    1000:
    QLEEEESARQ | KLQLEKVTTE | AKLKKLEEEQ | IILEDQNCKL | AKEKKLLEDR | 
    1050:
    IAEFTTNLTE | EEEKSKSLAK | LKNKHEAMIT | DLEERLRREE | KQRQELEKTR | 
    1100:
    RKLEGDSTDL | SDQIAELQAQ | IAELKMQLAK | KEEELQAALA | RVEEEAAQKN | 
    1150:
    MALKKIRELE | SQISELQEDL | ESERASRNKA | EKQKRDLGEE | LEALKTELED | 
    1200:
    TLDSTAAQQE | LRSKREQEVN | ILKKTLEEEA | KTHEAQIQEM | RQKHSQAVEE | 
    1250:
    LAEQLEQTKR | VKANLEKAKQ | TLENERGELA | NEVKVLLQGK | GDSEHKRKKV | 
    1300:
    EAQLQELQVK | FNEGERVRTE | LADKVTKLQV | ELDNVTGLLS | QSDSKSSKLT | 
    1350:
    KDFSALESQL | QDTQELLQEE | NRQKLSLSTK | LKQVEDEKNS | FREQLEEEEE | 
    1400:
    AKHNLEKQIA | TLHAQVADMK | KKMEDSVGCL | ETAEEVKRKL | QKDLEGLSQR | 
    1450:
    HEEKVAAYDK | LEKTKTRLQQ | ELDDLLVDLD | HQRQSACNLE | KKQKKFDQLL | 
    1500:
    AEEKTISAKY | AEERDRAEAE | AREKETKALS | LARALEEAME | QKAELERLNK | 
    1550:
    QFRTEMEDLM | SSKDDVGKSV | HELEKSKRAL | EQQVEEMKTQ | LEELEDELQA | 
    1600:
    TEDAKLRLEV | NLQAMKAQFE | RDLQGRDEQS | EEKKKQLVRQ | VREMEAELED | 
    1650:
    ERKQRSMAVA | ARKKLEMDLK | DLEAHIDSAN | KNRDEAIKQL | RKLQAQMKDC | 
    1700:
    MRELDDTRAS | REEILAQAKE | NEKKLKSMEA | EMIQLQEELA | AAERAKRQAQ | 
    1750:
    QERDELADEI | ANSSGKGALA | LEEKRRLEAR | IAQLEEELEE | EQGNTELIND | 
    1800:
    RLKKANLQID | QINTDLNLER | SHAQKNENAR | QQLERQNKEL | KVKLQEMEGT | 
    1850:
    VKSKYKASIT | ALEAKIAQLE | EQLDNETKER | QAACKQVRRT | EKKLKDVLLQ | 
    1900:
    VDDERRNAEQ | YKDQADKAST | RLKQLKRQLE | EAEEEAQRAN | ASRRKLQREL | 
    1950:
    EDATETADAM | NREVSSLKNK | LRRGDLPFVV | PRRMARKGAG | DGSDEEVDGK | 
    1960:
    ADGAEAKPAE | 
    3D Structure:
    N/A
    Predicted Eptitope:
    Please Sign in.
    EIAab Sequence  Vaild Sequence:
    Please Sign in.
    Related Databases
    SMR:
    KEGG:
    Pfam:
    MIM:
    UniGene:
    String:
    Uniprot:
     
    FOR
    ELISA Kit for Human Myosin-9
    Cat.:
    E0237h
    Price:
    Please sign in first.
    MSDS:
    Please sign in first.
    Packing:
    96T
    Range:
    Please sign in first.
    ELISA Kit for Human Myosin-9
    Cat.:
    E0237d
    Price:
    Please sign in first.
    MSDS:
    Please sign in first.
    Packing:
    96T
    Range:
    Please sign in first.
    ELISA Kit for Human Myosin-9
    Cat.:
    E0237m
    Price:
    Please sign in first.
    MSDS:
    Please sign in first.
    Packing:
    96T
    ELISA Kit for Human Myosin-9
    Cat.:
    E0237c
    Price:
    Please sign in first.
    MSDS:
    Please sign in first.
    Packing:
    96T
    ELISA Kit for Human Myosin-9
    Cat.:
    E0237r
    Price:
    Please sign in first.
    MSDS:
    Please sign in first.
    Packing:
    96T
    CLIA Kit for Human Myosin-9
    Cat.:
    U0237m
    Price:
    Please sign in first.
    MSDS:
    Please sign in first.
    Packing:
    96T
    CLIA Kit for Human Myosin-9
    Cat.:
    U0237c
    Price:
    Please sign in first.
    MSDS:
    Please sign in first.
    Packing:
    96T
    CLIA Kit for Human Myosin-9
    Cat.:
    U0237r
    Price:
    Please sign in first.
    MSDS:
    Please sign in first.
    Packing:
    96T
    CLIA Kit for Human Myosin-9
    Cat.:
    U0237h
    Price:
    Please sign in first.
    MSDS:
    Please sign in first.
    Packing:
    96T
    Range:
    Please sign in first.
    CLIA Kit for Human Myosin-9
    Cat.:
    U0237d
    Price:
    Please sign in first.
    MSDS:
    Please sign in first.
    Packing:
    96T
    Polyclonal Antibody for Human Myosin-9
    Polyclonal Antibody for Human Myosin-9
    Cat.:
    P0237Rb-r
    Price:
    Please sign in first.
    Packing:
    40ug/0.2ml
    Polyclonal Antibody for Human Myosin-9
    Polyclonal Antibody for Human Myosin-9
    Cat.:
    P0237Rb-m
    Price:
    Please sign in first.
    Packing:
    40ug/0.2ml
    Polyclonal Antibody for Human Myosin-9
    Cat.:
    P0237Rb-h
    Price:
    Please sign in first.
    Packing:
    40ug/0.2ml
    Monoclonal Antibody for Human Myosin-9
    Monoclonal Antibody for Human Myosin-9
    Monoclonal Antibody for Human Myosin-9
    Monoclonal Antibody for Human Myosin-9
    Monoclonal Antibody for Human Myosin-9
    Protein for Human Myosin-9
    Protein for Human Myosin-9
    Protein for Human Myosin-9
    Protein for Human Myosin-9
    Protein for Human Myosin-9

    R&D Technical Data
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    Precision
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    Recovery
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    Linearity
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    References
    1. 1.
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1)
    2. 2.
      "Vector-capping: a simple method for preparing a high-quality full-length cDNA library."
      Kato S. , Ohtoko K. , Ohtake H. , Kimura T.
      DNA Res.12:53-62(2005) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]
    3. 3.
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2)
      tissue: Spinal cord.
    4. 4.
      "Multiplex amplification and cloning of 5'-ends of cDNA by ligase-free recombination: Preparation of full-lemgth cDNA clones encoding motor proteins."
      Yamakawa H. , Kikuno R.F. , Nagase T. , Ohara O.
      Submitted (2007-01) to the EMBL/GenBank/DDBJ databases
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]
    5. 5.
      "The DNA sequence of human chromosome 22."
      Dunham I. , Hunt A.R. , Collins J.E. , Bruskiewich R. , Beare D.M. , Clamp M. , Smink L.J. , Ainscough R. , Almeida J.P. , Babbage A.K. , Bagguley C. , Bailey J. , Barlow K.F. , Bates K.N. , Beasley O.P. , Bird C.P. , Blakey S.E. , Bridgeman A.M. , more...
      Nature402:489-495(1999) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]
    6. 6.
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]
    7. 7.
      "Cellular myosin heavy chain in human leukocytes: isolation of 5' cDNA clones, characterization of the protein, chromosomal localization, and upregulation during myeloid differentiation."
      Toothaker L.E. , Gonzalez D.A. , Tung N. , Lemons R.S. , le Beau M.M. , Arnaout M.A. , Clayton L.K. , Tenen D.G.
      Blood78:1826-1833(1991) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [MRNA] OF 1-1337;TISSUE SPECIFICITY
    8. 8.
      "Complete sequencing and characterization of 21,243 full-length human cDNAs."
      Ota T. , Suzuki Y. , Nishikawa T. , Otsuki T. , Sugiyama T. , Irie R. , Wakamatsu A. , Hayashi K. , Sato H. , Nagai K. , Kimura K. , Makita H. , Sekine M. , Obayashi M. , Nishi T. , Shibahara T. , Tanaka T. , Ishii S. , more...
      Nat. Genet.36:40-45(2004) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1-1009
      tissue: Placenta.
    9. 9.
      "Human nonmuscle myosin heavy chains are encoded by two genes located on different chromosomes."
      Simons M. , Wang M. , McBride O.W. , Kawamoto S. , Yamakawa K. , Gdula D. , Adelstein R.S. , Weir L.
      Circ. Res.69:530-539(1991) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [MRNA] OF 1-715
    10. 10.
      Bienvenut W.V. , Claeys R.
      Submitted (2005-08) to the UniProtKB
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: PROTEIN SEQUENCE OF 2-47; 67-74; 126-139; 187-199; 203-225; 241-261; 290-299; 328-355; 359-387; 408-419; 476-494; 546-555; 581-613; 618-637; 645-651; 657-670; 683-693; 712-718; 721-731; 746-755; 765-775; 802-810; 824-829; 834-842; 861-867; 924-930; 995-1014; 1042-1048; 1052-1075; 1081-1099; 1136-1162; 1166-1191; 1261-1266; 1278-1295; 1302-1322; 1393-1400; 1405-1413; 1418-1433; 1484-1492; 1504-1513; 1519-1525; 1529-1555; 1558-1566; 1606-1612; 1614-1638; 1642-1648; 1662-1669; 1704-1724; 1794-1802; 1807-1828; 1857-1867; 1899-1912; 1923-1932 AND 1951-1960;CLEAVAGE OF INITIATOR METHIONINE;ACETYLATION AT ALA-2;IDENTIFICATION BY MASS SPECTROMETRY
      tissue: Platelet.
    11. 11.
      "Human nonmuscle myosin heavy chain mRNA: generation of diversity through alternative polyadenylylation."
      Saez C.G. , Myers J.C. , Shows T.B. , Leinwand L.A.
      Proc. Natl. Acad. Sci. U.S.A.87:1164-1168(1990) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [MRNA] OF 714-1960
    12. 12.
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: INTERACTION WITH SVIL
    13. 13.
      "Proteomic identification of proteins conjugated to ISG15 in mouse and human cells."
      Giannakopoulos N.V. , Luo J.K. , Papov V. , Zou W. , Lenschow D.J. , Jacobs B.S. , Borden E.C. , Li J. , Virgin H.W. , Zhang D.E.
      Biochem. Biophys. Res. Commun.336:496-506(2005) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: ISGYLATION
    14. 14.
      "Global, in vivo, and site-specific phosphorylation dynamics in signaling networks."
      Olsen J.V. , Blagoev B. , Gnad F. , Macek B. , Kumar C. , Mortensen P. , Mann M.
      Cell127:635-648(2006) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1943;IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]
      tissue: Cervix carcinoma.
    15. 15.
      "A probability-based approach for high-throughput protein phosphorylation analysis and site localization."
      Beausoleil S.A. , Villen J. , Gerber S.A. , Rush J. , Gygi S.P.
      Nat. Biotechnol.24:1285-1292(2006) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1943;IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]
      tissue: Cervix carcinoma.
    16. 16.
      "Toward a global characterization of the phosphoproteome in prostate cancer cells: identification of phosphoproteins in the LNCaP cell line."
      Giorgianni F. , Zhao Y. , Desiderio D.M. , Beranova-Giorgianni S.
      Electrophoresis28:2027-2034(2007) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1943;IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]
      tissue: Prostate cancer.
    17. 17.
      "Supervillin slows cell spreading by facilitating myosin II activation at the cell periphery."
      Takizawa N. , Ikebe R. , Ikebe M. , Luna E.J.
      J. Cell Sci.120:3792-3803(2007) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: INTERACTION WITH SVIL
    18. 18.
      "Phosphorylation analysis of primary human T lymphocytes using sequential IMAC and titanium oxide enrichment."
      Carrascal M. , Ovelleiro D. , Casas V. , Gay M. , Abian J.
      J. Proteome Res.7:5167-5176(2008) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1943;IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]
      tissue: T-cell.
    19. 19.
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1943;IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]
      tissue: Platelet.
    20. 20.
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: ASSOCIATION WITH END STAGE RENAL DISEASE
    21. 21.
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: ASSOCIATION WITH END STAGE RENAL DISEASE
    22. 22.
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]
      tissue: Cervix carcinoma.
    23. 23.
      "Large-scale phosphoproteome analysis of human liver tissue by enrichment and fractionation of phosphopeptides with strong anion exchange chromatography."
      Han G. , Ye M. , Zhou H. , Jiang X. , Feng S. , Jiang X. , Tian R. , Wan D. , Zou H. , Gu J.
      Proteomics8:1346-1361(2008) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1943;IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]
      tissue: Liver.
    24. 24.
      "Lys-N and trypsin cover complementary parts of the phosphoproteome in a refined SCX-based approach."
      Gauci S. , Helbig A.O. , Slijper M. , Krijgsveld J. , Heck A.J. , Mohammed S.
      Anal. Chem.81:4493-4501(2009) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]
    25. 25.
      "Polymorphisms in the non-muscle myosin heavy chain 9 gene (MYH9) are strongly associated with end-stage renal disease historically attributed to hypertension in African Americans."
      Freedman B.I. , Hicks P.J. , Bostrom M.A. , Cunningham M.E. , Liu Y. , Divers J. , Kopp J.B. , Winkler C.A. , Nelson G.W. , Langefeld C.D. , Bowden D.W.
      Kidney Int.75:736-745(2009) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: ASSOCIATION WITH END STAGE RENAL DISEASE
    26. 26.
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1943;IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]
    27. 27.
      "Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions."
      Mayya V. , Lundgren D.H. , Hwang S.-I. , Rezaul K. , Wu L. , Eng J.K. , Rodionov V. , Han D.K.
      Sci. Signal.2:RA46-RA46(2009) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-11 AND SER-1943;IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]
      tissue: Leukemic T-cell.
    28. 28.
      "Lysine acetylation targets protein complexes and co-regulates major cellular functions."
      Choudhary C. , Kumar C. , Gnad F. , Nielsen M.L. , Rehman M. , Walther T.C. , Olsen J.V. , Mann M.
      Science325:834-840(2009) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2; LYS-8; LYS-102; LYS-299; LYS-1024; LYS-1357; LYS-1392; LYS-1404; LYS-1410; LYS-1459 AND LYS-1638;IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]
    29. 29.
      "Myosin II motor proteins with different functions determine the fate of lamellipodia extension during cell spreading."
      Betapudi V.
      PLoS ONE5:E8560-E8560(2010) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: FUNCTION;SUBCELLULAR LOCATION
    30. 30.
      "Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis."
      Olsen J.V. , Vermeulen M. , Santamaria A. , Kumar C. , Miller M.L. , Jensen L.J. , Gnad F. , Cox J. , Jensen T.S. , Nigg E.A. , Brunak S. , Mann M.
      Sci. Signal.3:RA3-RA3(2010) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1714 AND SER-1943;IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]
      tissue: Cervix carcinoma.
    31. 31.
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]
    32. 32.
      "System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation."
      Rigbolt K.T. , Prokhorova T.A. , Akimov V. , Henningsen J. , Johansen P.T. , Kratchmarova I. , Kassem M. , Mann M. , Olsen J.V. , Blagoev B.
      Sci. Signal.4:RS3-RS3(2011) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1943;IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]
    33. 33.
      "Application of the wheat-germ cell-free translation system to produce high temperature requirement A3 (HtrA3) proteases."
      Singh H. , Makino S. , Endo Y. , Li Y. , Stephens A.N. , Nie G.
      BioTechniques52:23-28(2012) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: INTERACTION WITH HTRA3
    34. 34.
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]
    35. 35.
      "Human nonsyndromic hereditary deafness DFNA17 is due to a mutation in nonmuscle myosin MYH9."
      Lalwani A.K. , Goldstein J.A. , Kelley M.J. , Luxford W. , Castelein C.M. , Mhatre A.N.
      Am. J. Hum. Genet.67:1121-1128(2000) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANT DFNA17 HIS-705
    36. 36.
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANTS MHA/FTNS/SBS LYS-93; CYS-702; CYS-1165; HIS-1424 AND LYS-1841
    37. 37.
      "Mutation of MYH9, encoding non-muscle myosin heavy chain A, in May-Hegglin anomaly."
      Kelley M.J. , Jawien W. , Ortel T.L. , Korczak J.F.
      Nat. Genet.26:106-108(2000) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANTS MHA ILE-1155 AND LYS-1841
    38. 38.
      "Nonmuscle myosin heavy chain IIA mutations define a spectrum of autosomal dominant macrothrombocytopenias: May-Hegglin anomaly and Fechtner, Sebastian, Epstein, and Alport-like syndromes."
      Heath K.E. , Campos-Barros A. , Toren A. , Rozenfeld-Granot G. , Carlsson L.E. , Savige J. , Denison J.C. , Gregory M.C. , White J.G. , Barker D.F. , Greinacher A. , Epstein C.J. , Glucksman M.J. , Martignetti J.A.
      Am. J. Hum. Genet.69:1033-1045(2001) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANTS MHA/SBS/FTNS/EPS/APSM ASN-373; CYS-702; HIS-702; PRO-1114; ASN-1424; HIS-1424 AND LYS-1841
    39. 39.
      "Identification of six novel MYH9 mutations and genotype-phenotype relationships in autosomal dominant macrothrombocytopenia with leukocyte inclusions."
      Kunishima S. , Matsushita T. , Kojima T. , Amemiya N. , Choi Y.M. , Hosaka N. , Inoue M. , Jung Y. , Mamiya S. , Matsumoto K. , Miyajima Y. , Zhang G. , Ruan C. , Saito K. , Song K.S. , Yoon H.-J. , Kamiya T. , Saito H.
      J. Hum. Genet.46:722-729(2001) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANTS MHA/FTNS/SBS THR-95; CYS-1165; LEU-1165; 1205-LEU--GLN-1207 DEL; HIS-1424; ASN-1424; TYR-1424 AND LYS-1841;VARIANT VAL-1626
    40. 40.
      "Epstein syndrome: another renal disorder with mutations in the nonmuscle myosin heavy chain 9 gene."
      Seri M. , Savino M. , Bordo D. , Cusano R. , Rocca B. , Meloni I. , Di Bari F. , Koivisto P.A. , Bolognesi M. , Ghiggeri G.M. , Landolfi R. , Balduini C.L. , Zelante L. , Ravazzolo R. , Renieri A. , Savoia A.
      Hum. Genet.110:182-186(2002) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANT EPS HIS-702
    41. 41.
      "Expression of the nonmuscle myosin heavy chain IIA in the human kidney and screening for MYH9 mutations in Epstein and Fechtner syndromes."
      Arrondel C. , Vodovar N. , Knebelmann B. , Gruenfeld J.-P. , Gubler M.-C. , Antignac C. , Heidet L.
      J. Am. Soc. Nephrol.13:65-74(2002) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANTS FTNS/EPS LEU-96; LEU-1165; ASN-1424 AND LYS-1841;VARIANT TRP-1400;TISSUE SPECIFICITY
    42. 42.
      "Asp1424Asn MYH9 mutation results in an unstable protein responsible for the phenotypes in May-Hegglin anomaly/Fechtner syndrome."
      Deutsch S. , Rideau A. , Bochaton-Piallat M.-L. , Merla G. , Geinoz A. , Gabbiani G. , Schwede T. , Matthes T. , Antonarakis S.E. , Beris P.
      Blood102:529-534(2003) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: CHARACTERIZATION OF VARIANT ASN-1424
    43. 43.
      "Immunofluorescence analysis of neutrophil nonmuscle myosin heavy chain-A in MYH9 disorders: association of subcellular localization with MYH9 mutations."
      Kunishima S. , Matsushita T. , Kojima T. , Sako M. , Kimura F. , Jo E.-K. , Inoue C. , Kamiya T. , Saito H.
      Lab. Invest.83:115-122(2003) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANT FTNS/SBS CYS-1165;VARIANTS SBS LEU-1165 AND 1205-LEU--GLN-1207 DEL;VARIANTS MHA HIS-1424; ASN-1424; TYR-1424 AND LYS-1841;VARIANT EPS VAL-1816;VARIANT FTNS/MHA LYS-1841
    44. 44.
      "MYH9-related disease: may-Hegglin anomaly, Sebastian syndrome, Fechtner syndrome, and Epstein syndrome are not distinct entities but represent a variable expression of a single illness."
      Seri M. , Pecci A. , Di Bari F. , Cusano R. , Savino M. , Panza E. , Nigro A. , Noris P. , Gangarossa S. , Rocca B. , Gresele P. , Bizzaro N. , Malatesta P. , Koivisto P.A. , Longo I. , Musso R. , Pecoraro C. , Iolascon A. , more...
      Medicine (Baltimore)82:203-215(2003) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANT EPS HIS-702;VARIANTS FTNS GLN-910; ILE-1155 AND HIS-1424;VARIANTS MHA/SBS 1066-GLU--ALA-1072 DEL AND ASN-1424;VARIANT EPS/FTNS/MHA/SBS CYS-702
    45. 45.
      "Macrothrombocytopenia and progressive deafness is due to a mutation in MYH9."
      Mhatre A.N. , Kim Y. , Brodie H.A. , Lalwani A.K.
      Otol. Neurotol.24:205-209(2003) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANT MPSD ASN-1424
    46. 46.
      "Bladder exstrophy and Epstein type congenital macrothrombocytopenia: evidence for a common cause?"
      Utsch B. , DiFeo A. , Kujat A. , Karle S. , Schuster V. , Lenk H. , Jacobs U. , Mueller M. , Doetsch J. , Rascher W. , Reutter H. , Martignetti J.A. , Ludwig M. , Troebs R.-B.
      Am. J. Med. Genet. A140:2251-2253(2006) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANT EPS LEU-96
    47. 47.
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANT [LARGE SCALE ANALYSIS] ASN-810
    48. 48.
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: POSITION OF MUTATIONS IN MYH9-RELATED DISEASE
    Product Feedback Wall
    Hot Genes
    Atf2 ASPRO ACE ALCAM C19orf80 Trap1a KSR2 Gdf5
    Top Searches
    Ubiquitin-protein ligase Ubiquitin ELISA metalloproteinase Tumor necrosis Asprosin TRAP1A Alpha
    Why choose EIAAB
    Our products have been quoted by many publications in famous journals such as Cell; Cell Metabolism; Hepatology; Biomaterials.more
    Further Information
    About us Protein center Bank account Distributors Terms & Conditions Career eiaab.cn

    Copyright & copy www.eiaab.com2006-2016 All Rights Reserved    EIAab         Email:eiaab@eiaab.com

    Twitter